4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001571049-16-019927
CIK 0001600132operating
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:19 PM ET
Size
5.4 KB
Accession
0001571049-16-019927
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2016-11-11+466,141→ 466,141 totalExercise: $0.98Exp: 2026-11-11→ Common Stock (466,141 underlying)
Footnotes (1)
- [F1]This option was granted on November 11, 2016. This option vests in four equal installments over a four-year period from the date of grant, with the first installment vesting on the date that is one year following the date of the grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:19 PM ET
- Size
- 5.4 KB